Introduction Autism spectrum disorder (ASD) is an early-onset disorder with a prevalence of
1% among children and reported disability-adjusted life years of 4.31 million. Irritability is a …

Background There are over 53million children worldwide under five with developmental
disabilities who require effective interventions to support their health and well-being …

Abstract The World Health Organization's (WHO) integrated approach to primary care differs
from the traditional patient-centered approach to primary care, resulting in a gap that needs …

Autism spectrum disorder (ASD) is a neurodevelopmental condition that affects about 1% of
the population. It is characterized by deficits in social interaction and communication, as well …

Introduction Autism spectrum disorder (ASD) is a neurodevelopmental disorder affecting
approximately 3% of school-age children. The core symptoms are deficits in social …

Autism spectrum disorder (ASD; autism) is a heterogenous condition that varies in symptom
severity and is often accompanied by a range of behavioral problems. The common thread …

Background Since 2003 when memantine was first approved for use in the management of
moderate-severe Alzheimer's dementia, its use has become more widespread and is being …

Aims This systematic review and meta-analysis aimed to assess the efficacy of NMDA
antagonists in ASD (Autism Spectrum Disorder) on the core (communication and social …

Memantine: a novel treatment for children with developmental and epileptic encephalopathies |
Brain | Oxford Academic Skip to Main Content Advertisement Oxford Academic Journals Books …

This study aims to describe the utilisation of psychotropic medications in Australian autistic
children and adolescents. All children and adolescents with available Pharmaceutical …